(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0.52%19.82B | 10.50%13.88B | 9.84%6.76B | -16.86%26.61B | -22.22%19.72B | -24.65%12.56B | -27.70%6.16B | -3.08%32B | -1.57%25.36B | -2.89%16.68B |
Operating income | 0.52%19.82B | 10.50%13.88B | 9.84%6.76B | -16.86%26.61B | -22.22%19.72B | -24.65%12.56B | -27.70%6.16B | -3.08%32B | -1.57%25.36B | -2.89%16.68B |
Operating expenses | 1.43%-18.08B | -5.99%-12.19B | -7.56%-5.93B | 10.70%-24.45B | 15.78%-18.34B | 18.60%-11.5B | 23.01%-5.51B | -8.53%-27.37B | -13.78%-21.78B | -19.08%-14.12B |
Gross profit | 26.47%1.75B | 59.07%1.7B | 29.23%836.6M | -53.29%2.16B | -61.39%1.38B | -58.14%1.07B | -52.39%647.37M | -40.61%4.63B | -45.94%3.58B | -51.96%2.55B |
Selling expenses | 13.20%-147.21M | 6.90%-99.3M | 3.02%-49.3M | 4.62%-231M | 19.87%-169.6M | 22.74%-106.67M | 32.31%-50.84M | 17.49%-242.18M | 3.48%-211.65M | 6.48%-138.06M |
Administrative expenses | 5.80%-490.3M | 3.31%-317.44M | 4.29%-186.75M | 8.02%-690.32M | 2.39%-520.5M | 7.04%-328.3M | -2.12%-195.13M | 20.35%-750.55M | 30.33%-533.25M | 28.23%-353.17M |
Research and development expenses | -9.43%-901.81M | -10.69%-611.91M | -12.23%-307.81M | 9.75%-1.16B | 15.77%-824.08M | 19.12%-552.8M | 20.31%-274.28M | 11.25%-1.29B | 10.48%-978.39M | 9.71%-683.51M |
Profit from asset sales | -37.02%18.2M | 63.47%19.22M | 1,055.68%18.78M | -90.93%14.61M | 1,085.04%28.9M | 632.52%11.76M | 26.00%1.63M | 212.44%161.09M | -95.22%2.44M | -96.72%1.61M |
Revaluation surplus | 107.37%1.64M | 88.79%-2.22M | 77.63%-4.57M | -1.19%-25.56M | 67.83%-22.22M | 66.31%-19.82M | 67.44%-20.44M | 67.23%-25.25M | 19.65%-69.09M | 40.66%-58.81M |
-Changes in the fair value of other assets | 107.37%1.64M | 88.79%-2.22M | 77.63%-4.57M | -1.19%-25.56M | 67.83%-22.22M | 66.31%-19.82M | 67.44%-20.44M | 67.23%-25.25M | 19.65%-69.09M | 40.66%-58.81M |
Impairment and provision | -31.23%-213.96M | -47.49%-127.43M | -227.47%-68.34M | -251.82%-364.96M | -330.90%-163.05M | -268.79%-86.4M | 108.72%53.62M | 62.95%-103.74M | 82.59%-37.84M | 91.63%-23.43M |
-Other impairment is provision | -31.23%-213.96M | -47.49%-127.43M | -227.47%-68.34M | -251.82%-364.96M | -330.90%-163.05M | -268.79%-86.4M | 108.72%53.62M | 62.95%-103.74M | 82.59%-37.84M | 91.63%-23.43M |
Special items of operating profit | -37.91%432.89M | 421.84%341.28M | 1,327.23%242.6M | 406.91%842.39M | 300.58%697.15M | -47.73%65.4M | -72.49%17M | 10.04%166.18M | -44.28%174.03M | -43.57%125.13M |
Operating profit | 18.73%274.23M | 1,542.20%784.68M | 227.70%428.57M | -86.28%316.02M | -86.82%230.97M | -104.17%-54.41M | -81.55%130.78M | -50.68%2.3B | -60.07%1.75B | -64.16%1.31B |
Financing cost | -0.17%-1.35B | -0.82%-856.46M | 8.70%-421.08M | 6.38%-2.01B | 9.23%-1.35B | 16.80%-849.53M | 16.38%-461.2M | 10.09%-2.15B | 26.18%-1.49B | 22.59%-1.02B |
Special items of earning before tax | 88.34%-288.51K | 179.09%1.74M | 798.48%1.14M | -161.65%-16.06M | 88.06%-2.47M | 75.88%-2.2M | 105.20%126.36K | 5.38%26.05M | -137.50%-20.73M | -155.58%-9.11M |
Earning before tax | 3.85%-1.08B | 92.27%-70.04M | 102.61%8.62M | -1,038.01%-1.71B | -555.77%-1.12B | -429.05%-906.13M | -313.11%-330.3M | -92.10%182.27M | -89.89%245.68M | -88.23%275.38M |
Tax | -11.02%267.22M | -54.42%96.4M | -5.41%59.15M | 183.55%383.06M | 439.38%300.32M | 15,439.60%211.49M | 368.33%62.53M | 162.40%135.09M | 118.40%55.68M | 99.50%-1.38M |
After-tax profit from continuing operations | 1.22%-809.41M | 103.79%26.36M | 125.31%67.77M | -518.02%-1.33B | -371.91%-819.43M | -353.52%-694.64M | -303.34%-267.76M | -84.81%317.36M | -85.84%301.36M | -86.74%274M |
Earning after tax | 1.22%-809.41M | 103.79%26.36M | 125.31%67.77M | -518.02%-1.33B | -371.91%-819.43M | -353.52%-694.64M | -303.34%-267.76M | -84.81%317.36M | -85.84%301.36M | -86.74%274M |
Minority profit | -94.19%-99.31M | 65.14%-2.29M | 25.18%9.57M | -135.41%-45.35M | -184.13%-51.14M | -114.96%-6.56M | -56.96%7.65M | 429.86%128.07M | 211.97%60.79M | -3.25%43.86M |
Profit attributable to shareholders | 7.57%-710.1M | 104.16%28.65M | 121.13%58.2M | -776.89%-1.28B | -419.36%-768.29M | -398.98%-688.08M | -341.76%-275.41M | -90.84%189.29M | -88.98%240.58M | -88.61%230.14M |
Basic earnings per share | 12.95%-0.242 | 104.00%0.01 | 119.80%0.02 | -1,600.00%-0.45 | -563.33%-0.278 | -490.63%-0.25 | -415.63%-0.101 | -94.64%0.03 | -90.20%0.06 | -89.40%0.064 |
Diluted earnings per share | 12.95%-0.242 | 104.00%0.01 | 119.80%0.02 | -1,600.00%-0.45 | -563.33%-0.278 | -490.63%-0.25 | -415.63%-0.101 | -94.64%0.03 | -90.20%0.06 | -89.40%0.064 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data